Kumar Neil

Related Filers (3)

Other (5)

144
Friday, 11/17/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/17/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 5/17/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 5/3/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 4/5/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (55)

SC 13G/A
Friday, 2/16/2024
BridgeBio Pharma, Inc.: Major Shareholders
4
Monday, 11/20/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/18/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/18/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/5/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/7/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
BridgeBio Pharma, Inc.: Major Shareholders
4
Tuesday, 2/14/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/6/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/21/2022
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/18/2022
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/18/2022
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/18/2022
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/18/2022
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/18/2022
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
BridgeBio Pharma, Inc.: Major Shareholders
4
Tuesday, 12/7/2021
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/18/2021
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
3/A
Tuesday, 11/9/2021
LianBio: Initial statement of beneficial ownership of securities
3
Friday, 10/29/2021
LianBio: Initial statement of beneficial ownership of securities
4
Wednesday, 8/18/2021
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/16/2021
BridgeBio Pharma, Inc.: Major Shareholders
4
Friday, 2/12/2021
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
5
Friday, 2/12/2021
BridgeBio Pharma, Inc.: Annual statement of changes in beneficial ownership of securities
4
Wednesday, 11/18/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/18/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/5/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/6/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/10/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/3/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/6/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/5/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/9/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/6/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/3/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/4/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/14/2020
BridgeBio Pharma, Inc.: Major Shareholders
5/A
Friday, 2/14/2020
BridgeBio Pharma, Inc.: Annual statement of changes in beneficial ownership of securities
5
Thursday, 2/13/2020
BridgeBio Pharma, Inc.: Annual statement of changes in beneficial ownership of securities
4
Friday, 2/7/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/5/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/6/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/8/2019
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/3/2019
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/27/2019
BridgeBio Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/29/2019
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
5
Thursday, 2/14/2019
Eidos Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
4
Friday, 6/22/2018
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/19/2018
Eidos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More